Sees FY23 revenue up 1.5%-3.5%, consensus $7B.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on ZBH:
- Zimmer Biomet Announces Fourth Quarter and Full-Year 2022 Financial Results
- Increasing Medical Issues Bode Well for Zimmer Biomet Stock (NYSE:ZBH)
- Zimmer Biomet upgraded to Outperform from Sector Perform at RBC Capital
- Zimmer Biomet price target raised to $130 from $120 at Piper Sandler
- Zimmer Biomet to Acquire Embody, Inc.